TrialBiology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation2017

Consolidation Therapy for Newly Diagnosed Pediatric Patients with High-Risk Neuroblastoma Using Busulfan/Melphalan, Autologous Hematopoietic Cell Transplantation, Anti-GD2 Antibody, Granulocyte-Macrophage Colony-Stimulating Factor, Interleukin-2, and Haploidentical Natural Killer Cells.

Aimee C Talleur et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.